Insider Stock Trading History of Gergen Mark J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gergen Mark J since year 2005. The trader's CIK number is 1373110. At the time of this reporting, Gergen Mark J is the Executive VP, COO of Mirati Therapeutics, Inc. . (stock ticker symbol MRTX). See this page for all insider trading activities at Mirati Therapeutics, Inc. .

Note that in the past Gergen Mark J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gergen Mark J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-01-15 MRTX Mirati Therapeutics, Inc. Option Ex 15,000 8.50 127,500
2016-01-15 MRTX Mirati Therapeutics, Inc. Sale 10,000 25.92 259,210
2012-03-01 AMLN Amylin Pharmaceuticals Inc Sale 1,846 17.11 31,585
2012-02-23 AMLN Amylin Pharmaceuticals Inc Sale 7,518 17.03 128,031
2007-11-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-11-01 AMLN Amylin Pharmaceuticals Inc Sale 500 44.00 22,000
2007-10-03 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-10-03 AMLN Amylin Pharmaceuticals Inc Sale 500 50.00 25,000
2007-10-01 AMLN Amylin Pharmaceuticals Inc Sale 500 49.83 24,915
2007-10-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-09-04 AMLN Amylin Pharmaceuticals Inc Option Ex 1,000 16.80 16,800
2007-09-04 AMLN Amylin Pharmaceuticals Inc Sale 1,000 49.50 49,500
2007-08-07 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-08-07 AMLN Amylin Pharmaceuticals Inc Sale 500 50.00 25,000
2007-08-01 AMLN Amylin Pharmaceuticals Inc Sale 500 46.50 23,250
2007-08-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-07-24 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-07-24 AMLN Amylin Pharmaceuticals Inc Sale 500 45.00 22,500
2007-07-02 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-07-02 AMLN Amylin Pharmaceuticals Inc Sale 500 41.20 20,600
2007-06-01 AMLN Amylin Pharmaceuticals Inc Option Ex 1,000 16.80 16,800
2007-06-01 AMLN Amylin Pharmaceuticals Inc Sale 1,000 46.16 46,160
2007-05-21 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-05-21 AMLN Amylin Pharmaceuticals Inc Sale 500 45.00 22,500
2007-05-01 AMLN Amylin Pharmaceuticals Inc Sale 500 41.25 20,625
2007-05-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-04-02 AMLN Amylin Pharmaceuticals Inc Sale 500 37.47 18,735
2007-04-02 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-03-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-03-01 AMLN Amylin Pharmaceuticals Inc Sale 500 37.75 18,875
2007-02-01 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-02-01 AMLN Amylin Pharmaceuticals Inc Sale 500 38.75 19,375
2007-01-03 AMLN Amylin Pharmaceuticals Inc Option Ex 500 16.80 8,400
2007-01-03 AMLN Amylin Pharmaceuticals Inc Sale 500 36.29 18,145

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gergen Mark J (Executive VP, COO of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.